ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,978, issued on Oct. 6, was assigned to INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (Gwangju, South Korea).

"Tumor-targeting Salmonella gallinarum strain and use thereof" was invented by Hyon El Choy (Gwangju, South Korea), Jae Ho Jeong (Gwangju, South Korea), Dae Jin Lim (Gwangju, South Korea), Hyung Ju Lim (Gwangju, South Korea) and Kwangsoo Kim (Gwangju, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a tumor-targeting Salmonella gallinarum strain and the use thereof. The tumor-targeting Salmonella gallinarum strain has excellent tumor proliferation inhibitory activity and enables tumor-specific ta...